FDx Advisors’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-10,321
| Closed | -$315K | – | 552 |
|
|
2023
Q4 | $315K | Sell |
10,321
-255
| -2% | -$7.78K | 0.02% | 514 |
|
|
2023
Q3 | $334K | Sell |
10,576
-6,036
| -36% | -$191K | 0.03% | 443 |
|
|
2023
Q2 | $677K | Buy |
16,612
+2,762
| +20% | +$113K | 0.04% | 380 |
|
|
2023
Q1 | $483K | Hold |
13,850
| – | – | 0.02% | 423 |
|
|
2022
Q4 | $483K | Buy |
13,850
+156
| +1% | +$5.44K | 0.02% | 423 |
|
|
2022
Q3 | $766K | Buy |
13,694
+1,164
| +9% | +$65.1K | 0.03% | 324 |
|
|
2022
Q2 | $649K | Buy |
12,530
+2,419
| +24% | +$125K | 0.02% | 408 |
|
|
2022
Q1 | $735K | Sell |
10,111
-13
| -0.1% | -$945 | 0.02% | 399 |
|
|
2021
Q4 | $1.2M | Buy |
10,124
+26
| +0.3% | +$3.07K | 0.03% | 326 |
|
|
2021
Q3 | $1.36M | Sell |
10,098
-1,969
| -16% | -$264K | 0.04% | 285 |
|
|
2021
Q2 | $1.95M | Sell |
12,067
-7,296
| -38% | -$1.18M | 0.06% | 203 |
|
|
2021
Q1 | $1.55M | Sell |
19,363
-3,046
| -14% | -$244K | 0.06% | 205 |
|
|
2020
Q4 | $1.22M | Buy |
22,409
+513
| +2% | +$27.9K | 0.05% | 231 |
|
|
2020
Q3 | $435K | Buy |
21,896
+9,824
| +81% | +$195K | 0.02% | 409 |
|
|
2020
Q2 | $254K | Buy |
+12,072
| New | +$254K | 0.01% | 478 |
|